Daiichi and GAIA join forces to commercialise digital cardiovascular therapy
Pharma companies are increasingly combining the strengths of pharmaceutical and digital health interventions to improve outcomes.
Therapy Area
Guardant Health acquires MetaSight amid positive 2026 financial outlook
UK’s NICE greenlights Abbott’s CardioMEMS heart failure sensor
Pulse Biosciences and MD Anderson to study nPulse for thyroid cancer
Roche gains CE Mark for bacterial vaginosis/candida vaginitis assay
Lunit seeks FDA clearance for breast cancer risk prediction model
Örebro University researchers develop new AI models for dementia
Cordance to advance ultrasound platform trial with new funding
